Skip to main content

FDA News

Featured Article
Changes in FDA procedures meant to speed approvals for medications may have resulted in less exacting standards, a new analysis suggests.
The FDA has issued a Class II recall for a prescription treatment used for patients with severe acne.
Back to Top